12th Symposium: Synthetic and Medicinal Chemistry
Capabilities
The 12th Chemistry Symposium
Pharmaron held its 12th Symposium on Synthetic and Medicinal Chemistry on September 13, 2025, in Beijing, China.
Advancements in Synthetic and Medicinal Chemistry
This symposium featured seven world-class guest speakers from academia and the life science industry with topics spanning from novel metal and organic catalysis, process development, molecule glues for intractable targets, dual target inhibition, to AI-enabled drug discovery. Thousands of Pharmaron chemists across Beijing, Xi’an, Ningbo, Tianjin, Shaoxing, Qingdao, Hoddesdon, UK and Coventry, Rhode Island, US sites, attended this unique opportunity to learn from and interact with the speakers and attendees, stimulating creative thinking.
The goal of this symposium is to spark innovation, as that is the foundation of Pharmaron’s learning culture and a building block for continued success.
12th Chemistry Symposium Presentations:
- Dr. Hartmut Beck, Bayer AG, Germany
- Discovery of BAY 3389934 Hydrochloride, a Potent and Selective Small Molecule Dual Factor IIa/Xa Inhibitor with Short Half-life for the Acute Treatment of Sepsis-Induced Coagulopathy (SIC)
- Prof. Matthias Beller, Leibniz-Institut für Katalyse, Germany
- With a Little Help from My Friends – The Importance of Ligands and Supports in Catalysis
- Dr. Meizhong Jin, AstraZeneca, US
- Targeting the Intractables: The Power of Molecular Glues
- Dr. Matthew Maddess, Merck Sharp & Dohme, US
- Bridging Discovery and Development: Impact of Synthesis Innovation in Drug Discovery
- Prof. David Nicewicz, The University of North Carolina at Chapel Hill, US
- New Avenues in Synthesis via Organic Photoredox Catalysis
- Dr. Philip Pye, JNJ Innovative Medicine, US
- Challenges in Discovery Process Research at J&J
- Dr. Eric Talbot, Isomorphic Labs, UK
- Reimagining Drug Discovery Using an AI-First Platform